Clinicopathological Correlates of γδ T Cell Infiltration in Triple-Negative Breast Cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinicopathological Correlates of γδ T Cell Infiltration in Triple-Negative Breast Cancer
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 4, Pages 765
Publisher
MDPI AG
Online
2021-02-13
DOI
10.3390/cancers13040765
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis
- (2020) Guoxuan Gao et al. BMC CANCER
- Pembrolizumab for Early Triple-Negative Breast Cancer
- (2020) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- γδ T-cell receptors derived from breast cancer-infiltrating T lymphocytes mediate antitumor reactivity
- (2020) Anke Janssen et al. Cancer Immunology Research
- Identification of a regulatory Vδ1 gamma delta T cell subpopulation expressing CD73 in human breast cancer
- (2020) Ghita Chabab et al. JOURNAL OF LEUKOCYTE BIOLOGY
- BRCA1 Promoter Hypermethylation is Associated with Good Prognosis and Chemosensitivity in Triple-Negative Breast Cancer
- (2020) William Jacot et al. Cancers
- Progress Toward Identifying Exact Proxies for Predicting Response to Immunotherapies
- (2020) Aleksandra Filipovic et al. Frontiers in Cell and Developmental Biology
- High-Dose Cyclophosphamide Administration Orchestrates Phenotypic and Functional Alterations of Immature Dendritic Cells and Regulates Th Cell Polarization
- (2020) Lei Bao et al. Frontiers in Pharmacology
- Aberrantly Expressed Embryonic Protein NODAL Alters Breast Cancer Cell Susceptibility to γδ T Cell Cytotoxicity
- (2020) Gabrielle M. Siegers et al. Frontiers in Immunology
- Prognostic Value of CXCR2 in Breast Cancer
- (2020) Florence Boissière-Michot et al. Cancers
- Diversity of Tumor-Infiltrating, γδ T-Cell Abundance in Solid Cancers
- (2020) Ghita Chabab et al. Cells
- Integration of tumour infiltrating lymphocytes, programmed cell-death ligand-1, CD8 and FOXP3 in prognostic models for triple-negative breast cancer: Analysis of 244 stage I–III patients treated with standard therapy
- (2020) Maria Vittoria Dieci et al. EUROPEAN JOURNAL OF CANCER
- Inhibition of PI3K pathway increases immune infiltrate in muscle-invasive bladder cancer
- (2019) Edith Borcoman et al. OncoImmunology
- The neoepitope landscape of breast cancer: implications for immunotherapy
- (2019) Pooja Narang et al. BMC CANCER
- Atezolizumab plus nab-paclitaxel as first-line treatment for unresectable, locally advanced or metastatic triple-negative breast cancer (IMpassion130): updated efficacy results from a randomised, double-blind, placebo-controlled, phase 3 trial
- (2019) Peter Schmid et al. LANCET ONCOLOGY
- An innate-like Vδ1+ γδ T cell compartment in the human breast is associated with remission in triple-negative breast cancer
- (2019) Yin Wu et al. Science Translational Medicine
- Oncogenic signaling pathways associated with immune evasion and resistance to immune checkpoint inhibitors in cancer
- (2019) Yoshie Kobayashi et al. SEMINARS IN CANCER BIOLOGY
- PI3K Inhibitors in Breast Cancer Therapy
- (2019) Haley Ellis et al. Current Oncology Reports
- Prognostic value of androgen receptor and FOXA1 co-expression in non-metastatic triple negative breast cancer and correlation with other biomarkers
- (2018) Séverine Guiu et al. BRITISH JOURNAL OF CANCER
- Immunohistochemical Detection of γ/δ T Lymphocytes in Formalin-fixed Paraffin-embedded Tissues
- (2018) Achim A. Jungbluth et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtype
- (2018) Kenichi Harano et al. PLoS One
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cdh1 and Pik3ca Mutations Cooperate to Induce Immune-Related Invasive Lobular Carcinoma of the Breast
- (2018) Yeji An et al. Cell Reports
- Tumor Mutational Burden and Response Rate to PD-1 Inhibition
- (2017) Mark Yarchoan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Assessment of tumor-infiltrating TCRVγ9Vδ2 γδ lymphocyte abundance by deconvolution of human cancers microarrays
- (2017) Marie Tosolini et al. OncoImmunology
- Low dose cyclophosphamide: Mechanisms of T cell modulation
- (2016) Mutsa Tatenda Madondo et al. CANCER TREATMENT REVIEWS
- Relevance of Tumor-Infiltrating Immune Cell Composition and Functionality for Disease Outcome in Breast Cancer
- (2016) Rico D. Bense et al. JNCI-Journal of the National Cancer Institute
- Genetic alterations of triple negative breast cancer by targeted next-generation sequencing and correlation with tumor morphology
- (2016) Paul S Weisman et al. MODERN PATHOLOGY
- Relevance of Tumor-Infiltrating Immune Cell Composition and Functionality for Disease Outcome in Breast Cancer
- (2016) Rico D. Bense et al. JNCI-Journal of the National Cancer Institute
- Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection
- (2016) Brian D. Lehmann et al. PLoS One
- Clinical validity of tumor-infiltrating lymphocytes analysis in patients with triple-negative breast cancer
- (2015) G. Pruneri et al. ANNALS OF ONCOLOGY
- High EGFR protein expression and exon 9 PIK3CA mutations are independent prognostic factors in triple negative breast cancers
- (2015) William Jacot et al. BMC CANCER
- IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis
- (2015) Seth B. Coffelt et al. NATURE
- The prognostic landscape of genes and infiltrating immune cells across human cancers
- (2015) Andrew J Gentles et al. NATURE MEDICINE
- The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
- (2014) R. Salgado et al. ANNALS OF ONCOLOGY
- The prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancer: a meta-analysis
- (2014) Ezzeldin M. Ibrahim et al. BREAST CANCER RESEARCH AND TREATMENT
- IL-17A Produced by T Cells Promotes Tumor Growth in Hepatocellular Carcinoma
- (2014) S. Ma et al. CANCER RESEARCH
- γδT17 Cells Promote the Accumulation and Expansion of Myeloid-Derived Suppressor Cells in Human Colorectal Cancer
- (2014) Pin Wu et al. IMMUNITY
- Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199
- (2014) Sylvia Adams et al. JOURNAL OF CLINICAL ONCOLOGY
- Murine CD27(-) V 6(+) T cells producing IL-17A promote ovarian cancer growth via mobilization of protumor small peritoneal macrophages
- (2014) M. Rei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Histological Analysis of γδ T Lymphocytes Infiltrating Human Triple-Negative Breast Carcinomas
- (2014) Jose Villacorta Hidalgo et al. Frontiers in Immunology
- BRCA1 promoter hypermethylation, 53BP1 protein expression and PARP-1 activity as biomarkers of DNA repair deficit in breast cancer
- (2013) William Jacot et al. BMC CANCER
- Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes
- (2013) H. Masuda et al. CLINICAL CANCER RESEARCH
- Molecular Characterization of Basal-Like and Non-Basal-Like Triple-Negative Breast Cancer
- (2013) A. Prat et al. ONCOLOGIST
- Tumor-Infiltrating T Lymphocytes Predict Clinical Outcome in Human Breast Cancer
- (2012) C. Ma et al. JOURNAL OF IMMUNOLOGY
- Characterization of Human γδ T Lymphocytes Infiltrating Primary Malignant Melanomas
- (2012) Adriana Cordova et al. PLoS One
- Adjuvant early breast cancer systemic therapies according to daily used technologies
- (2011) W. Jacot et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Potential candidate biomarkers for heterogeneity in triple-negative breast cancer (TNBC)
- (2010) Eun Yoon Cho et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Pattern of metastatic spread in triple-negative breast cancer
- (2008) Rebecca Dent et al. BREAST CANCER RESEARCH AND TREATMENT
- Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype
- (2008) M. C.U. Cheang et al. CLINICAL CANCER RESEARCH
- PI(3) kinase is associated with a mechanism of immunoresistance in breast and prostate cancer
- (2008) C A Crane et al. ONCOGENE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started